Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2.
Byung Soo KimSeong Jin JoSangWoong YounKristian ReichCarine SaadounChia-Ling ChangYa-Wen YangYu-Huei HuangTsen Fang TsaiPublished in: Dermatology and therapy (2023)
ClinicalTrials.gov identifiers: VOYAGE 1 [NCT02207231] and VOYAGE 2 [NCT02207244].
Keyphrases